Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0684
D

Failure to Update Eye Drop Administration per Ophthalmologist Recommendation

Longmeadow, Massachusetts Survey Completed on 05-07-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident received treatment and care in accordance with professional standards of practice. Specifically, the facility did not follow up on an ophthalmologist's recommendation to increase the administration of Refresh Optive Mega-3 Ophthalmic Solution from two times per day to four times per day. The recommendation was documented in a consultation report and reviewed and accepted by the facility provider, as indicated by their initials. However, the physician order for the eye drops remained at two times per day, and the medication administration records showed that the resident continued to receive the drops only twice daily. The resident involved had a history of Myasthenia Gravis, dementia, bilateral ectropion, and recurrent conjunctivitis. During an observation, the resident was noted to have red, watery lower eyelids and a yellow crusty substance on the left upper lid. Interviews with staff confirmed that the process for updating the medication order after a consultant's recommendation was not followed, resulting in the resident not receiving the increased frequency of eye drops as recommended by the ophthalmologist.

An unhandled error has occurred. Reload 🗙